PM360

NOVEMBER 9, 2023

Award-winning health and wellness advertising agency AbelsonTaylor Group received the inaugural ACE Aspire Award for its employee Psychological Safety Initiative from the Healthcare Businesswomen’s Association (HBA). In 2022, AbelsonTaylor developed and implemented a large-scale, ongoing Psychological Safety initiative for its 300 employees.

Safety 111

Safety Healthcare Healthcare Recruitment 111

pharmaphorum

JANUARY 21, 2022

As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022? Join us on Friday 21 January at 2.00pm CET to find out how life science companies can stay ahead of the competition in 2022.

Competition 52

Competition Healthcare Healthcare 52

PM360

JULY 13, 2023

During the COVID-19 pandemic, we saw healthcare organizations spend and scramble to implement numerous virtual care point solutions. The global healthcare IT market was valued at $280.3 Solving this will require reassembling these solutions to put the patient at the center of the healthcare experience. fitness trackers).

Healthcare 98

Healthcare Healthcare Consulting Healthcare Provider 98

Nixon Gwilt Law

DECEMBER 16, 2021

What can Healthcare and Life Sciences businesses and investors anticipate for the healthcare industry in 2022? We asked our team five direct questions about innovations in healthcare, life sciences, and digital health in the coming year: What healthcare trends or opportunities are you most excited about?

Healthcare 52

Healthcare Healthcare Food and Drug Administration Ethics 52

pharmaphorum

JANUARY 19, 2023

Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022. Nonetheless, she also mentioned that, over the summer, Lord Prior had written an article published in the British Medical Journal entitled ‘Precision public health must be at the centre of modern healthcare’. Highly unlikely.”

Pharma 78

Pharma Competition Healthcare Healthcare 78

Clarify Health

NOVEMBER 22, 2023

Today’s healthcare providers are seeing significantly more patients than they did a decade ago – many of whom are often sicker and have more complex care needs. But consolidation in healthcare markets is not with its critics, with some experts raising concerns over increasing prices due to decreased competition and eliminating services.

Leads 52

Leads Healthcare Healthcare Patients 52

European Pharmaceutical Review

APRIL 11, 2024

As of September 2022, there were around 39 biosimilars approved and 22 marketed, the report stated. This has resulted in “increased competition and price pressure, driving the growth of the biosimilar market”. The latter of which is important in “gaining a competitive advantage”, the author noted. million by 2032, at 17.6

Marketing 91

Marketing Competition Manufacturing Healthcare Provider 91

Scott’s Directories

OCTOBER 19, 2022

One of the most competitive industries in the United States is healthcare. government reveal that in 2019, spending on healthcare increased to about $3.8 But despite the success recorded in the healthcare industry, it’s often tough for many B2B healthcare marketers to get into. Statistics from the U.S.

Healthcare 52

Healthcare Healthcare Marketing Media 52

Pharmaceutical Technology

JANUARY 30, 2023

According to GlobalData’s Drugs database, there were 22 prophylactic vaccines in development for COVID-19 with sales forecasts available in H2 2022. According to GlobalData’s Drugs database, there were 22 prophylactic vaccines in development for COVID-19 with sales forecasts available in H2 2022.

Sales 52

Sales Competition Leads Medicine 52

MedCity News

JUNE 1, 2023

Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. Access and accessibility aren’t the same All three regulations have good intentions, but they unfortunately demonstrate an all-too-familiar refrain in healthcare. The message here is clear: Patients need to know what they’re paying for.

Patients 104

Patients Healthcare Healthcare Electronics 104

Clarivate

APRIL 18, 2024

Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52

Retail Healthcare Healthcare Physicians 52

European Pharmaceutical Review

NOVEMBER 30, 2023

The company stated that based on the IQVIA’s 2022 report: The impact of biosimilar competition in Europe , as of 2022 “the cumulative savings at list prices from the impact of biosimilar competition in Europe reached over €30 billion. Furthermore, since the launch of biosimilars these provided nearly 4.5

Marketing 94

Marketing Medicine Competition Distribution 94

Clarify Health

JUNE 8, 2023

Healthcare leaders are swimming in a deluge of data. Without the right healthcare business intelligence tools to make sense of it, it’s easy to drown in the sea of data points. Navigating the data is of the utmost importance for today’s savvy healthcare leaders. Relying on old approaches won’t cut it.

Healthcare 52

Healthcare Healthcare Physicians Patients 52

Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarify Health

FEBRUARY 18, 2022

Health plans need to supplement rate intelligence with provider performance analytics to maintain market competitiveness, ensure advantageous provider negotiations, and affirm value. Rates and performance insights are critical to assessing the value of care, but they’re not as simple to acquire as it may seem.

Networking 52

Networking Competition Engineering Marketing 52

Clarify Health

SEPTEMBER 5, 2023

Use healthcare provider data to boost network performance Assessing provider performance is one of the key challenges of network design and optimization. Referral pattern tracking is one of the lowest-hanging fruits when it comes to optimizing healthcare networks. However, doing so properly is time-consuming.

Networking 52

Networking Healthcare Provider Healthcare Healthcare 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 93

Medicine Healthcare Healthcare Pharma 93

Clarify Health

OCTOBER 13, 2021

Healthcare price transparency continues to grow, with health insurers required to release cost-sharing estimates beginning in 2022. What’s new for healthcare price transparency in 2021 ? The American healthcare system is ushering in a new era of health cost transparency. Why is price transparency important in healthcare?

Healthcare 52

Healthcare Healthcare Insurance Networking 52

Clarify Health

DECEMBER 21, 2021

The No Surprises Act and Transparency in Coverage Rule The past two years have been monumental for healthcare transparency and reporting regulations. The No Surprises Act (NSA), signed into law in December 2020, and the Transparency in Coverage Rule (TiC), published in October 2020, will have significant implications for health plans in 2022.

Healthcare 52

Healthcare Healthcare Networking Healthcare Provider 52

pharmaphorum

DECEMBER 15, 2022

Healthcare Provider (HCP) marketing. In the same vein, patient advocates and influencers might share their personal journeys and help raise awareness of their condition and healthcare needs. The post The evolving role of social media in healthcare appeared first on. This is a quickly growing area of insight-gathering.

Media 86

Media Healthcare Healthcare Education 86

Pharma Marketing Network

DECEMBER 17, 2021

Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022. While large corporations with mega campuses will start to “return to campus” in 2022, if they haven’t already, few are drawing hard lines around a full-time return. In this article, R.J.

Pharma 105

Pharma Marketing Engineering Digital Media 105

Clarify Health

AUGUST 3, 2023

Healthcare prices in the U.S. Complying with the regulations won’t be enough for healthcare delivery organizations that want to thrive in this new, more transparent environment. While price transparency does present new, interesting challenges to healthcare delivery organizations, it also opens the door for new growth opportunities.

Networking 52

Networking Healthcare Healthcare Patients 52

Pharmaceutical Technology

JULY 28, 2022

FDI experts at Investment Monitor have highlighted the following list of factors as most important to life sciences companies considering a greenfield investment in 2022: labour, education, industry clusters, domestic market, infrastructure, business environment, costs and quality of life. appeared first on Pharmaceutical Technology.

Transportation 52

Transportation Education Marketing Networking 52

Impetus Digital

MARCH 15, 2024

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. However, with rapid growth comes growing pains.

Recruitment 78

Recruitment Healthcare Provider Patients Healthcare 78

Clarivate

OCTOBER 10, 2022

Clarivate oncology experts share key takeaways from the 2022 ESMO Congress and their expected impact on the drug treatment landscape and patients. Read on to for insights from our analysts on: Global highlights from ESMO 2022. Key ESMO 2022 highlights from Mainland China. Seven global highlights from ESMO 2022.

Marketing 52

Marketing Safety Patients Competition 52

European Pharmaceutical Review

NOVEMBER 16, 2023

With procurement practices across Europe having a strong price focus, over time, this could impact the “sustainability of biosimilars and decrease competition, as well as reducing supply reliability”, the report acknowledged. “As Act4Biosimilars is supported by its founding sponsor, Sandoz.

Marketing 87

Marketing Education Competition Consulting 87

Modus

OCTOBER 28, 2022

As one of the largest sectors in the healthcare industry, there are currently over 900 medical device companies ( IBIS 2022 ) making it a continually fast-growing and competitive market. Most sales reps in this field face similar challenges such as: engaging potential buyers. being responsive to prospects and customers.

Medical 52

Medical Prospecting Sales Competition 52

Impetus Digital

JANUARY 3, 2023

A couple of years ago, I first wrote about how social media’s role in the Pharma and healthcare sectors has been growing exponentially. Healthcare Provider (HCP) Marketing. In the same vein, patient advocates and influencers might share their personal journeys and help raise awareness of their condition and healthcare needs.

Media 52

Media Healthcare Healthcare Recruitment 52

Eversana Intouch

MARCH 15, 2022

How do you remain inspired – and inspiring – when you’re living in 2022, with everything that means? ON OUR PURPOSE Truly top-tier healthcare speakers abounded, from Surgeon General Dr. Vivek Murthy to Pfizer CEO Albert Bourla, and spoke at length. This is only a peek into our insights. Memorable Relevant Quotes.

Doctors 40

Doctors Healthcare Healthcare Media 40

Clarivate

DECEMBER 6, 2022

In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.

Networking 52

Networking Healthcare Healthcare Competition 52

Clarify Health

MARCH 26, 2024

As patients become savvier about healthcare costs and spending, hospitals must be proactive about providing them with the necessary information to find a facility and care provider that best fits their needs and budget. Enriching price transparency with quality and outcomes data to uncover value In 2022, healthcare spending in the U.S.

Healthcare 52

Healthcare Healthcare Patients Competition 52

Clarify Health

AUGUST 16, 2022

In the past, healthcare was considered a “recession-proof” industry, but as we continue to see the effects of labor shortages, global supply chain issues, and the recession are having on provider organizations today – it’s clear that they are no longer as immune to economic downturns as we once believed them to be.

Physicians 52

Physicians Competition Marketing Healthcare 52

Nixon Gwilt Law

NOVEMBER 16, 2021

If you are in the digital health industry, particularly the remote patient monitoring (“RPM”) space, you have likely heard of the remote therapeutic monitoring (“RTM”) codes finalized in the 2022 Medicare Physician Fee Schedule Final Rule (the “Final Rule”). blood pressure monitors and pulse oximeters) as a new service line?

Physicians 52

Physicians FDA Medical Manufacturing 52

MedCity News

JUNE 16, 2023

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 101

Pharma Food and Drug Administration Recruitment Pharmacology 101

Clarivate

JULY 5, 2023

The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn. Clarivate research indicates biosimilar competition will drive down prices and relative market share of HUMIRA ® in the U.S. from 91% in 2023 to 36% by 2031.

Marketing 97

Marketing Physicians Manufacturing Competition 97

pharmaphorum

JULY 14, 2022

Bayer’s venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business. The two companies said the transaction is expected to close by the end of 2022, subject to approval by the competition authorities.

Competition 83

Competition Pharma Sales Medicine 83

PM360

JUNE 26, 2023

In its 2022 edition, the Access to Medicine Foundation report 2 analyzed the access strategy of 180 products across the top 20 pharmaceutical companies, of which 102 are on the WHO essential medicine list. These partnerships can be with local governments, healthcare providers, local startups, and non-governmental organizations.

Medicine 98

Medicine Marketing Pharma Manufacturing 98